Brian Henry

Can light absorption and photostability data be used to assess the photosafety risks in patients for a new drug molecule?

Brian Henry, Christopher J. Foti, Karen M. Alsante · Journal of Photochemistry and Photobiology B Biology · 2009 · 1.9K citations

Natural Sciences, Medicinal Chemistry, Pharmacology +16

Characterization of Enhanced Behavioral Responses tol-DOPA Following Repeated Administration in the 6-Hydroxydopamine-Lesioned Rat Model of Parkinson's Disease

Brian Henry, Alan R. Crossman, Jonathan M. Brotchie · Experimental Neurology · 1998 · 187 citations

Life Sciences, Neuroscience, Pharmacology +12

Characterisation of human saliva as a platform for oral dissolution medium development

Sally Gittings, Neil Turnbull, Brian Henry et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2015 · 171 citations · Full text

Dentistry, Oral Biology, Dissolution Testing +9

Stimulation of cannabinoid receptors reduces levodopa‐induced dyskinesia in the MPTP‐lesioned nonhuman primate model of Parkinson's disease

Susan H. Fox, Brian Henry, Michael P. Hill et al. · Movement Disorders · 2002 · 164 citations

Life Sciences, Neuroscience, Pharmacology +17

Effect of Repeatedl-DOPA, Bromocriptine, or Lisuride Administration on Preproenkephalin-A and Preproenkephalin-B mRNA Levels in the Striatum of the 6-Hydroxydopamine-Lesioned Rat

Brian Henry, Alan R. Crossman, Jonathan M. Brotchie · Experimental Neurology · 1999 · 157 citations

Life Sciences, Neuroscience, Pharmacology +15